Polymorphism of the MUC1 mucin gene is associated with susceptibility to lung adenocarcinoma and poor prognosis

Oncology Reports

Volumn 14, Issue 1, 2005, Pages 185-189

  Mitsuta, Kazuhiro ^a   Yokoyama, Akihito ^a   Kondo, Keiichi ^a   Nakajima, Masamitsu ^a   Arita, Ken Ichi ^b   Kohno, Nobuoki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

Author keywords

Adenocarcinoma; Immune surveillance; Non small cell lung cancer; Polymorphism; Tandem repeat

Indexed keywords

CA 15-3 ANTIGEN;

ADENOCARCINOMA; AGED; ALLELE; ARTICLE; COMPARATIVE STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; LUNG TUMOR; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ALLELES; CA-15-3 ANTIGEN; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 24644509417     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Jentoft N: Why are proteins O-glycosylated? Trends Biochem Sci 15: 291-294, 1990.
2. Denda-Nagai K and Irimura T: MUC1 in carcinoma-host interactions. Glycoconj J 17: 649-658, 2000. (Pubitemid 32480350)
3. Swallow DM, Gendler S, Griffiths B, Corney G, Taylor-Papadimitriou J and Bramwell ME: The human tumour-associated epithelial mucins are coded by an expressed hypervariable gene locus PUM. Nature 328: 82-84, 1987. (Pubitemid 17103587)
4. Kyo K, Parkes M, Takei Y, et al: Association of ulcerative colitis with rare VNTR alleles of the human intestinal mucin gene, MUC3. Hum Mol Genet 8: 307-311, 1999. (Pubitemid 29054272)
5. McGuckin MA, Walsh MD, Hohn BG, Ward BG and Wright RG: Prognostic significance of MUC1 epithelial mucin expression in breast cancer. Hum Pathol 26: 432-439, 1995.
6. Dong Y, Walsh MD, Cummings MC, Wright RG, Khoo SK, Parsons PG and McGuckin MA: Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours. J Pathol 183: 311-317, 1997. (Pubitemid 27505217)
7. Seregni E, Botti C, Lombardo C, Cantoni A, Bogni A, Cataldo I and Bombardieri E: Pattern of mucin gene expression in normal and neoplastic lung tissues. Anticancer Res 16: 2209-2213, 1996. (Pubitemid 26265567)
8. Nagata S, Tanaka S, Haruma K, Kitadai Y, Yoshihara M, Shimamoto F, Kohno N and Chayama K: MUC1 and cathepsin D expression in early colorectal carcinoma showing V type pit pattern. Int J Oncol 19: 665-672, 2001.
9. Tanimoto T, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G, Shimamoto F and Kohno N: MUC1 expression in intramucosal colorectal neoplasms. Possible involvement in histogenesis and progression. Oncology 56: 223-231, 1999. (Pubitemid 29161292)
10. Aoki R, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G, Shimamoto F and Kohno N: MUC-1 expression as a predictor of the curative endoscopic treatment of submucosally invasive colorectal carcinoma. Dis Colon Rectum 41: 1262-1272, 1998. (Pubitemid 28477976)
11. Masaki Y, Oka M, Ogura Y, et al: Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma. Hepatogastroenterology 46: 2240-2245, 1999. (Pubitemid 29454075)
12. Kimura T, Tanaka S, Haruma K, Sumii K, Kajiyama G, Shimamoto F and Kohno N: Clinical significance of MUC1 and E-cadherin expression, cellular proliferation, and angiogenesis at the deepest invasive portion of colorectal cancer. Int J Oncol 16: 55-64, 2000.
13. Hiraga Y, Tanaka S, Haruma K, et al: Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer. Oncology 55: 307-319, 1998. (Pubitemid 28279672)
14. Ligtenberg MJ, Buijs F, Vos HL and Hilkens J: Suppression of cellular aggregation by high levels of episialin. Cancer Res 52: 2318-2324, 1992.
15. Wesseling J, van der Valk SW and Hilkens J: A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol Biol Cell 7: 565-577, 1996. (Pubitemid 26112564)
16. Agrawal B, Krantz MJ, Reddish MA and Longenecker BM: Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2. Nat Med 4: 43-49, 1998. (Pubitemid 28133078)
17. Irimura T, Mclsaac AM, Carlson DA, et al: Soluble factor in normal tissues that stimulates high-molecular-weight sialoglycoprotein production by human colon carcinoma cells. Cancer Res 50: 3331-3338, 1990. (Pubitemid 20190141)
18. Zhang K, Sikut R and Hansson GC: A MUC1 mucin secreted from a colon carcinoma cell line inhibits target cell lysis by natural killer cells. Cell Immunol 176: 158-165, 1997. (Pubitemid 27145763)
19. Van de Wiel-van Kemenade E, Ligtenberg MJ, de Boer AJ, et al: Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. J Immunol 151: 767-776, 1993.
20. Kitamura H, Yonezawa S, Tanaka S, Kim YS and Sato E: Expression of mucin carbohydrates and core proteins in carcinomas of the ampulla of Vater: their relationship to prognosis. Jpn J Cancer Res 87: 631-640, 1996. (Pubitemid 26235555)
21. Gendler S, Taylor-Papadimitriou J, Duhig T, Rothbard J and Burchell J: A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J Biol Chem 263: 12820-12823, 1988.
22. Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, et al: Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem 265: 15286-15293, 1990.
23. Toribara NW, Gum JR Jr, Culhane PJ, Lagace RE, Hicks JW, Petersen GM and Kim YS: MUC-2 human small intestinal mucin gene structure. Repeated arrays and polymorphism. J Clin Invest 88: 1005-1013, 1991.
24. Toribara NW, Roberton AM, Ho SB, et al: Human gastric mucin. Identification of a unique species by expression cloning. J Biol Chem 268: 5879-5885, 1993. (Pubitemid 23090922)
25. Kondo K, Kohno N, Yokoyama A and Hiwada K: Decreased MUC1 expression induces E-cadherin-mediated cell adhesion of breast cancer cell lines. Cancer Res 58: 2014-2019, 1998. (Pubitemid 28217481)
26. Spicer AP, Rowse GJ, Lidner TK and Gendier SJ: Delayed mammary tumor progression in Muc-1 null mice. J Biol Chem 270: 30093-30101, 1995. (Pubitemid 26001684)
27. Carvalho F, Seruca R, David L, et al: MUC1 gene polymorphism and gastric cancer - an epidemiological study. Glycoconj J 14: 107-111, 1997. (Pubitemid 27104501)
28. Silva F, Carvalho F, Peixoto A, et al: MUC1 gene polymorphism in the gastric carcinogenesis pathway. Eur J Hum Genet 9: 548-552, 2001. (Pubitemid 32750496)
29. Vinall LE, King M, Novelli M, et al: Altered expression and allelic association of the hypervariable membrane mucin MUC1 in Helicobacter pylori gastritis. Gastroenterology 123: 41-49 2002. (Pubitemid 34747524)
30. Huiping C, Kristjansdottir S, Jonasson JG, Magnusson J, Egilsson V and Ingvarsson S: Alterations of E-cadherin and beta-catenin in gastric cancer. BMC Cancer 1:16, 2001.
31. Carvalho F, Peixoto A, Steffensen R, Amorim A, David L and Sobrinho-Simoes M: MUC1 gene polymorphism does not explain the different incidence of gastric cancer in Portugal and Denmark. Ann Hum Genet 63: 187-191, 1999. (Pubitemid 29471961)